Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma
- 1 March 2011
- journal article
- review article
- Published by Elsevier in Cancer Genetics
- Vol. 204 (3) , 113-121
- https://doi.org/10.1016/j.cancergen.2011.03.001
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- Copy number variation at 1q21.1 associated with neuroblastomaNature, 2009
- Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH studyThe Lancet Oncology, 2009
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeBritish Journal of Cancer, 2009
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature, 2008
- Activating mutations in ALK provide a therapeutic target in neuroblastomaNature, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingOncogene, 2005
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996